When new drugs come to market, they are either a better version of an established class, a new delivery method, or a whole new class with a steep learning curve. This week, in our two lead articles, we look at some new compounds and some new delivery systems that could …

Two of the four exciting treatment options currently being trialed could change the way the disease is treated long term.

New exciting treatment options currently being trialed could change the way the disease is treated long term.

Study answers questions of risk difference based on demographics.

Medication use may be associated with increased risk of mortality.

New study assesses increased risk of type 2, most beneficial method of raising vitamin D levels.

SGLT-2 inhibitors, GLP-1 agonists, and DPP-4 inhibitors compared in reducing mortality and cardiovascular events in patients with type 2.

Do you refer or provide education for all of your newly diagnosed prediabetes patients? Follow the link to share your response.

How many new “first-in-class” treatments for diabetes are in the diabetes pipeline as of May 2018? A. 7 B. 28 C. 56 D. 107 E. 152 Follow the link for the answer.

Centralize all your medical communication in one beautiful, HIPAA compliant, cloud-based app. It's so simple, you'll love it! Communicate directly with patients, teams & colleagues; secure real time messaging & file sharing, and more.